| Rank |
Approach |
Evidence |
Mechanism / Rationale |
Notes |
| 1 |
Weight loss if overweight/obese |
Best direct evidence in PsA |
Reduces metabolic inflammation, adipokine burden, and joint inflammatory load; may improve treatment response. |
Highest-yield natural strategy when excess weight is present. |
| 2 |
Regular exercise / physical activity |
Good supportive evidence |
Improves pain, stiffness, function, fatigue, muscle support, and cardiometabolic health. |
Strong adjunct for joint symptoms and overall health. |
| 3 |
Mediterranean-style diet / antioxidant-rich whole-food diet |
Moderate evidence |
May reduce systemic inflammatory tone; provides polyphenols, fiber, unsaturated fats, and better metabolic support. |
Best antioxidant strategy is diet pattern rather than antioxidant pills. |
| 4 |
Intermittent fasting / time-restricted eating |
Early limited evidence |
May improve inflammatory signaling and metabolic regulation; possible benefit for CRP, enthesitis, and disease activity. |
Promising but still exploratory. |
| 5 |
Omega-3 (fish / fish oil) |
Mixed evidence |
Shifts eicosanoids toward less inflammatory profiles and may modestly reduce inflammatory tone. |
Reasonable adjunct, but not a top-tier PsA joint intervention. |
| 6 |
Vitamin D |
Weak PsA-specific treatment evidence |
More relevant for deficiency correction, bone support, and immune modulation than for direct joint control. |
Most relevant when levels are low. |
| Rank |
Pathway / Axis |
Why It Matters in PsA Joints |
Helpful Modulation |
Support Level |
| 1 |
IL-23 → Th17/Tc17 → IL-17A/F |
Core inflammatory axis in psoriatic arthritis; active in synovium, enthesis, and related tissues. |
Reduce excessive IL-23 / IL-17 signaling and downstream cytokine/chemokine output. |
Very high |
| 2 |
TNF-α / NF-κB inflammatory axis |
Major validated cytokine pathway driving inflammation, tissue injury, and amplification of disease activity. |
Reduce TNF / NF-κB-driven inflammatory signaling and matrix damage. |
Very high |
| 3 |
JAK / STAT3 signaling |
Supports cytokine signaling relevant to synovial and entheseal inflammation. |
Dampen excessive JAK / STAT3 inflammatory activity. |
High |
| 4 |
Myeloid / inflammasome amplification (IL-1β, IL-6, GM-CSF) |
Amplifies synovitis, pain, recruitment of inflammatory cells, and osteoclastogenic signaling. |
Reduce IL-1β, IL-6, and GM-CSF inflammatory amplification. |
High |
| 5 |
RANKL / M-CSF / osteoclastogenesis |
Important for bone erosions and osteoclast-mediated damage. |
Reduce osteoclast differentiation and bone resorption pressure. |
High |
| 6 |
DKK1 / Wnt / BMP bone-remodeling balance |
PsA involves both erosions and abnormal new bone formation. |
Rebalance remodeling rather than simply suppress all bone formation. |
Moderate to high |
| 7 |
COX-2 / 5-LOX / eicosanoid signaling |
Contributes to inflammatory pain, swelling, and leukocyte recruitment. |
Reduce excess prostaglandin and leukotriene inflammatory tone. |
Moderate |
| 8 |
KEAP1-NRF2 / oxidative stress-redox balance |
Oxidative imbalance may reinforce inflammatory signaling and tissue injury. |
Improve antioxidant defense and redox resilience. |
Moderate |
| 9 |
Obesity / adipokine / metabolic inflammation axis |
Obesity is linked to worse disease activity and poorer response. |
Reduce metabolic inflammation and adverse adipokine signaling. |
Moderate |
| 10 |
Gut microbiome / barrier / immune-metabolite axis |
Gut dysbiosis and barrier changes may influence systemic immune activation. |
Support gut barrier function and more favorable immune-metabolic signaling. |
Moderate |
| Natural Product / Class |
Main PsA-Relevant Pathways |
Mechanistic Rationale |
Direct PsA Joint Evidence |
Practical Read |
| Omega-3 (EPA/DHA) |
IL-17-related signaling; TNF/NF-κB tone; eicosanoids / resolution pathways |
May shift lipid mediators toward less inflammatory profiles and reduce inflammatory signaling. |
Mixed / weak |
Most practical food/supplement adjunct, but not a strong standalone PsA joint therapy. |
| Curcumin / Turmeric |
NF-κB; JAK/STAT3; MAPK; IL-17 / IFN-γ; redox signaling |
Broad anti-inflammatory and signaling-modulating effects relevant to psoriatic disease biology. |
Very limited direct evidence |
Reasonable mechanistic adjunct; stronger biology than clinical PsA proof. |
| Boswellia / Boswellic acids |
5-LOX; NF-κB; COX-2; leukotrienes |
Notable leukotriene / 5-LOX angle with broader anti-inflammatory effects. |
No strong direct PsA joint trials |
Plausible adjunct, especially for eicosanoid-driven inflammation. |
| Ginger |
NF-κB; COX / LOX; inflammatory pain pathways |
Anti-inflammatory and antioxidant actions with arthritis-relevant pathway effects. |
Indirect only |
Plausible low-to-moderate adjunct; evidence is not PsA-specific. |
| EGCG / Green tea catechins |
IL-17 / IL-23-related inflammation; oxidative stress; keratinocyte hyperproliferation |
Immune-regulatory and antioxidant effects; mainly supported in psoriasis/preclinical models. |
Mostly psoriasis / preclinical |
Interesting adjunct, but not proven for PsA joints. |
| Sulforaphane |
KEAP1-NRF2; oxidative stress; TH17-related inflammation; autoimmune signaling |
Strong redox / NRF2 rationale with anti-inflammatory effects in preclinical models. |
Preclinical / indirect |
Good mechanistic candidate for the NRF2-redox tier. |
| Quercetin |
NF-κB; PI3K/AKT/GLUT1; inflammatory cell signaling |
Multi-target anti-inflammatory effects with arthritis relevance. |
Weak direct PsA evidence |
Mechanistically attractive, clinically still speculative for PsA. |
| Resveratrol |
NF-κB; oxidative stress; inflammatory mediators; SIRT1/AMPK-linked effects |
May reduce inflammatory signaling and support metabolic/redox regulation. |
Very limited for PsA |
Interesting but not near the top for real-world PsA use. |
| Piperlongumine |
NLRP3 inflammasome; ROS-sensitive inflammatory signaling; FLS proliferation/migration; MMPs |
Research-stage anti-inflammatory candidate with RA/psoriasis-model relevance. |
Research-stage only |
Experimental; not a practical PsA supplement at present. |
| Shikonin |
JAK/STAT; TNF-driven synoviocyte signaling; macrophage polarization; psoriasis inflammation |
Biologically interesting for synovitis and immune-cell signaling. |
Research-stage only |
Experimental; mainly of mechanistic interest. |